Literature DB >> 21667009

Outcomes of high- and low-intensity rehabilitation programme for persons in chronic phase after Guillain-Barré syndrome: a randomized controlled trial.

Fary Khan1, Julie F Pallant, Bhasker Amatya, Louisa Ng, Alexandra Gorelik, Caroline Brand.   

Abstract

OBJECTIVE: To assess the effectiveness of a high- vs low--intensity multidisciplinary ambulatory rehabilitation programme over 12 months for persons in the chronic phase after Guillain-Barré syndrome (pwGBS) in an Australian community cohort.
METHOD: A total of 79 pwGBS, recruited from a tertiary hospital, were randomized to a treatment group (n = 40) for an individualized high-intensity programme, or a control group (n = 39) for a lower intensity programme. The primary outcome the Functional Independence Measure (FIM) motor subscale assessed "activity limitation"; while secondary measures for "participation" included: World Health Organization Quality of Life; Depression, Anxiety Stress Scale; and Perceived Impact Problem Profile (PIPP) scales. All outcome measures were assessed at baseline and at 12 months.
RESULTS: Intention to treat analysis of data from 69 participants (treatment n = 35, control n = 34) showed reduced disability in the treatment group in post-treatment FIM domains (mobility, transfers, sphincter control and locomotion; all p < 0.005) and PIPP scores (relationships; p = 0.011), with moderate-to-small effect sizes (r = 0.36-0.23). The treatment group compared with control group showed significant improvement in function (FIM scores): 68% vs 32%.
CONCLUSION: Higher intensity rehabilitation compared with less intense intervention reduces disability in pwGBS in later stages of recovery. Further information on rehabilitation modalities and impact on quality of life is needed.

Entities:  

Mesh:

Year:  2011        PMID: 21667009     DOI: 10.2340/16501977-0826

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  11 in total

Review 1.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

Review 2.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

3.  Influence of Exercise on Patients with Guillain-Barré Syndrome: A Systematic Review.

Authors:  Nicholas Simatos Arsenault; Pierre-Olivier Vincent; Bai He Shen Yu; Robin Bastien; Aaron Sweeney
Journal:  Physiother Can       Date:  2016       Impact factor: 1.037

Review 4.  Organization of Rehabilitation Services in Randomized Controlled Trials: Which Factors Influence Functional Outcome? A Systematic Review.

Authors:  Cecilie Røe; Erik Bautz-Holter; Nada Andelic; Helene Lundgaard Søberg; Boya Nugraha; Christoph Gutenbrunner; Andrea Boekel; Marit Kirkevold; Grace Engen; Juan Lu
Journal:  Arch Rehabil Res Clin Transl       Date:  2022-04-13

5.  Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study.

Authors:  Valeria Prada; Federico Massa; Alexander Salerno; Davide Fregosi; Alessandro Beronio; Carlo Serrati; Antonio Mannironi; Giovanni Mancardi; Angelo Schenone; Luana Benedetti
Journal:  Neurol Sci       Date:  2019-10-04       Impact factor: 3.307

6.  Interventions for promoting physical activity in people with neuromuscular disease.

Authors:  Katherine Jones; Fiona Hawke; Jane Newman; James Al Miller; Joshua Burns; Djordje G Jakovljevic; Grainne Gorman; Douglass M Turnbull; Gita Ramdharry
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

7.  Observer blind randomised controlled trial of a tailored home exercise programme versus usual care in people with stable inflammatory immune mediated neuropathy.

Authors:  Claire M White; Robert D Hadden; Sarah F Robert-Lewis; Paul R McCrone; Jane L Petty
Journal:  BMC Neurol       Date:  2015-08-21       Impact factor: 2.474

8.  Functional outcomes and efficiency of rehabilitation in a national cohort of patients with Guillain-Barré syndrome and other inflammatory polyneuropathies.

Authors:  Roxana Alexandrescu; Richard John Siegert; Lynne Turner-Stokes
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

9.  Guillain-Barré syndrome: prevalence and long-term factors impacting bladder function in an Australian community cohort.

Authors:  Bhasker Amatya; Fary Khan; Michael Whishaw; Julie F Pallant
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

Review 10.  Neuropsychiatric manifestations in inflammatory neuropathies: A systematic review.

Authors:  Yusuf A Rajabally; Stefano Seri; Andrea E Cavanna
Journal:  Muscle Nerve       Date:  2016-05-10       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.